Elektra Health
10 known investors
Elektra Health is a virtual menopause care platform combining telemedicine, coaching, education and community.
Also known as Elektra
Founders & leadership

Investors · 10
Also in the syndicate · 2
Company profile
researched Aug 2026Elektra Health operates a digital health platform focused on menopause and midlife women's health. Its offering has four components: telemedicine visits with board-certified, menopause-trained clinicians who can order labs and prescribe medication; evidence-based educational content covering common menopause symptoms such as sleep problems, hot flashes and sexual health; 1:1 support from an "Elektra Coach" who provides non-clinical lifestyle, nutrition and emotional support; and a private member community with virtual events featuring menopause experts.
Clinical care follows guidelines from The Menopause Society and is limited to FDA-approved hormonal and non-hormonal therapies, including patches, pills, rings, sprays, gels, local vaginal hormone therapy, oral contraceptives used as hormone therapy, and FDA-approved treatments for hypoactive sexual desire disorder (flibanserin, bremelanotide). Elektra states it does not prescribe compounded or non-FDA-approved medications, does not order saliva or urine-based hormone testing, does not provide medical weight-loss management, and does not sell products. Clinicians also address menopause-adjacent conditions such as high cholesterol, hypothyroidism, hypertension and anxiety or depression. Initial clinician visits are 30 minutes with 15-minute follow-ups; coaching calls are 30 minutes. Care is telemedicine-only and positioned as complementary to, not a replacement for, a patient's local gynecologist or primary care provider, with referrals available.
The company frames the market opportunity around a care gap: it cites that only about 20% of OB/GYN residency programs offer menopause training and that 70% of women who seek menopause care do not receive treatment. Elektra also references its own 2023 actuarial study finding that women diagnosed with menopause incur 45% higher healthcare spend, and a 2023 clinical study with the University of Rochester in which 92% of respondents reported improved knowledge, awareness and access to trusted menopause experts after using the platform.
Founding story
Elektra Health was co-founded by Alessandra Henderson and Jannine Versi, who describe the company as female-founded and mission-driven around "smashing the menopause taboo." Versi, who serves as CEO, previously worked at Google, in the Obama Administration and the White House, was on the founding team of Cityblock Health and an early hire at Valera Health, and is an alumna of the University of Pennsylvania and Harvard Business School.
Business model
Elektra sells virtual menopause care to individual consumers and, through an "Elektra for organizations" offering, to health plans, self-insured employers and health systems. Clinical services are billed through insurance, with the company stating wide coverage across commercial plans and Medicaid/Medicare, and a separate education and community membership platform is offered alongside clinical care. A $50 fee applies to appointments cancelled with less than 24 hours' notice. Elektra states it does not monetize supplements, products or medications and is not paid to feature brands.
Revenue comes from clinical telemedicine visits and coaching reimbursed by or contracted with insurers and employer/health-plan customers, plus access to an education and community membership platform; the company explicitly does not sell products or take payment for product recommendations.
Traction
The company reports having helped thousands of women access menopause care, a 97% patient recommendation rate, and 87% of women reporting a more favorable opinion of their health plan for offering Elektra. A 2023 study with the University of Rochester reported 92% of respondents saw improvements in knowledge, awareness and access to trusted menopause experts. Enterprise relationships include Mass General Brigham Health Plan, EmblemHealth, Reddit and LVMH.
Latest developments
The February 2024 financing round led by UPMC Enterprises was earmarked for expanding Elektra's care delivery platform across payers, self-insured employers and new markets. The leadership team listed on the company site includes CEO and Co-Founder Jannine Versi, Chief Medical Officer Nora Lansen, and Chief Financial Officer Rachel Amalfitano.
▸Full profile — market position, technology, go-to-market, geography, history
Market position
A menopause-focused digital health company operating in women's midlife health, backed by strategic and venture investors including UPMC Enterprises, Wavemaker 360, Flare Capital Partners and the Seven Seven Six (776) fund, and contracting with payers and health systems such as Mass General Brigham Health Plan and EmblemHealth. As of February 2024 it reported $7.6 million in total equity financing raised.
Elektra positions itself against both conventional short in-person visits and product-selling menopause vendors: it pairs each patient with both a clinician and a coach, provides whole-person care including labs, prescriptions and lifestyle support, offers ongoing follow-up plus education and community rather than a single visit, limits prescribing to FDA-approved hormonal and non-hormonal options, and emphasizes broad insurance coverage including Medicaid and Medicare. Clinicians are women's health specialists sub-specialized in menopause, with several holding Menopause Society Certified Practitioner credentials.
Technology
A virtual care platform delivering video visits, secure patient-portal messaging, a menopause assessment questionnaire, personalized care and wellness plans, more than 100 hours of evidence-based educational content, virtual events and a private peer community. The company supports secure direct communication with clinical practices whose EHR synchronizes with Athena, and coordinates with outside clinicians by call, fax and email.
Go-to-market
Direct-to-consumer acquisition via the company website (menopause assessment, free intro call, online booking, and phone/text at (646) 760-6669), combined with enterprise distribution through partnerships with payers, health systems and employers. Named organizational partners include Mass General Brigham Health Plan, EmblemHealth, Reddit and LVMH. Content marketing (blog, patient stories, virtual events) and insurance coverage are used as adoption drivers.
Women navigating perimenopause, menopause and the following midlife decades in the U.S., referenced as a population of roughly 50 million currently in menopause; on the enterprise side, health plans, self-insured employers and health systems. Patients with conditions outside the platform's scope (e.g., new cancer patients undergoing chemotherapy, or those taking hormones for fertility or gender-affirming care) are generally referred elsewhere.
Geography
United States. The company is headquartered in New York, New York; clinicians provide telemedicine care in select states while coaches support patients in all states. Team members are distributed, with staff based in locations including Seattle, Chicago and Portland, Oregon.
History
By 2023 Elektra had produced an actuarial study on menopause-related healthcare spend and conducted a clinical study with the University of Rochester presented at the North American Menopause Society annual meeting. In February 2024 the company announced $3.3 million in new equity financing led by UPMC Enterprises, bringing total equity raised to $7.6 million, and added Kathryn Heffernan (UPMC Enterprises) and Dr. Monica Jain (Wavemaker 360) to its board of directors alongside Craig Ball (UPMC), Katelin Cruise (Seven Seven Six) and Vic Lanio (Flare Capital Partners).
Compiled by commissioned research from 8 cited public sources — announcements, filings, and press listed under research sources below.
Key figures
latest reportedCompany-reported or press-reported figures, each dated to when it was claimed — not independently audited.
Timeline · 4
launches, deals, and filingsElektra Health announced $3.3 million in new equity financing led by UPMC Enterprises with participation from Wavemaker 360 and existing investors Flare Capital Partners and Seven Seven Six Fund, bringing total equity raised to $7.6 million. Proceeds are to expand its care delivery platform across payers, self-insured employers and new markets.
$3.3M source ↗
Kathryn Heffernan of UPMC Enterprises and Dr. Monica Jain of Wavemaker 360 joined Elektra Health's board of directors in connection with the February 2024 financing.
Elektra works with employers and health plans across the U.S., including Mass General Brigham Health Plan and EmblemHealth; the company website also lists Reddit and LVMH among organizations offering Elektra.
A clinical study conducted in partnership with the University of Rochester on the effect of Elektra's digital menopause education, care and community platform on mid-life women was presented as a poster at the 2023 North American Menopause Society Annual Meeting in Philadelphia.
Dated company events from announcements, filings, and press; legal rows summarize public dockets and regulator releases.
In the news
▸Research sources · 8
primary sources listed
- Elektra Healthelektrahealth.com · web
8 public sources were cited for this profile; the first-party ones are listed here.
Frequently asked questions
- What does Elektra Health do?
- Elektra Health is a virtual menopause care platform combining telemedicine, coaching, education and community.
- Who founded Elektra Health?
- Elektra Health was founded by Alessandra Henderson.
- Who are Elektra Health's investors?
- Elektra Health's investors include Chloe Capital, City Light, Everywhere Ventures, Flare Capital Partners, Human Ventures, Seven Seven Six, The Fund, Wavemaker Three-Sixty Health.


